Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F0B4A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $124,497
Award facts
- Contract value 100% obligated
- $124,496.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $124,496.72 by the Defense Logistics Agency on February 4, 2026, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of February 5, 2026, and performance location in Conshohocken, PA. The delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which holds the primary IDC with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2031. The parent company's pharmaceutical supply contracts support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with an extensive portfolio of medications across multiple therapeutic domains. This delivery order for Jardiance, a diabetes management medication, exemplifies the company's role as a critical vendor in the federal medical procurement supply chain, delivering both brand-name and generic pharmaceuticals to support military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F0B4A?
SPE2DR26F0B4A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F0B4A worth?
The government has obligated $124,497 on SPE2DR26F0B4A.
Is contract SPE2DR26F0B4A an order under another contract?
Yes. SPE2DR26F0B4A is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0B4A competed?
The extent of competition for SPE2DR26F0B4A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award